Market Tracker

05/22 6:01pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

17.45
Delayed Data
As of May 22
 +0.20 / +1.16%
Today’s Change
7.26
Today|||52-Week Range
17.63
+80.83%
Year-to-Date

Today’s Trading

Previous close17.25
Today’s open17.20
Day’s range16.97 - 17.58
Volume794,018
Average volume (3 months)1,352,341
Market cap$2.2B
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+24.32%
Earnings growth (this year)+15.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+37.47%
P/E ratioNM
Price/Sales15.72
Price/Book53.05

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+0.54+1.03%
NVAXNovavax Inc+0.01+0.11%
ESPREsperion Therapeutic...-5.83-5.12%
RDUSRadius Health Inc0.000.00%
Data as of 4:00pm ET, 05/22/2015

Financials

Last reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.12
Annual revenue (last year)$75.3M
Annual profit (last year)-$68.4M
Net profit margin-90.76%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts